OPMI LUMERA 700 from Carl Zeiss Meditec Receives Design Award

OPMI LUMERA 700 from Carl Zeiss Meditec Receives Design Award

ID: 20147

(Thomson Reuters ONE) -
Carl Zeiss Meditec AG / OPMI LUMERA 700 from Carl Zeiss Meditec Receives Design Award processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement.

Latest surgical microscope for the ophthalmic surgeon impresses not only users,
but also designers


JENA - 03. May 2010
A red dot award for high design quality now also adorns the OPMI(® )LUMERA 700
surgical microscope. The 30-member international jury has honored both the
excellent conception and outstanding design of this leading edge surgical
microscope for ophthalmology.

In addition to the assessment criteria of innovativeness, functionality and
quality, the OPMI LUMERA 700 was able to score with the red dot jury due to its
ease of use and longevity. The jury confirmed the opinion of surgeons and
doctors from everyday practice: the technology of Stereo Coaxial Illumination
(SCI) is innovative and, with its outstanding image quality and stable, bright
red reflex, provides cataract surgeons with effective support in their work. The
functionality of the RESIGHT fundus viewing system, which displays the back of
the eye with superb clarity and detail in retinal surgery, was also highlighted
by the jury. In addition to the legendary optical quality associated with the
ZEISS brand, the integration of functions enables not only excellent ergonomics
and stress-free surgery for the ophthalmologist, but also optimal outcomes for
the patient. The integrated keratosope permits visualization of the corneal
curvature during the surgery. In addition, OPMI LUMERA 700 adapts automatically
to the field of surgery: when the RESIGHT 700 fundus viewing system is moved
into position, the Invertertube E and the MediLive Trio Eye video camera
immediately switch to the retinal mode. The result for the surgeon: an upright,
bright microscope and video image. To support the surgical team, OPMI LUMERA




700 also features an assistant's microscope and a video camera in HD or SD
quality.

OPMI LUMERA 700 outshone competitors' systems in the contest not least because
of its ease of use and user-friendliness. Intuitive and straightforward
operation is possible via the touchscreen. By enclosing all potentially
obstructive or interfering factors such as cables, the housing is an optimally
self-contained unit. This means that the eye of the user is immediately directed
to the key controls for the innovative assistance functions and the cleaning
process is considerably simplifed. The foot control panel is also operated
without cables. To ensure further workflow streamlining in the future, OPMI
LUMERA 700 is already equipped for exchanging information with other systems
used by the ophthalmologist.

"All products that received the red dot design award had to convince a jury of
international experts. These products stand out through their excellent designs
and innovativeness and were able to successfully demonstrate their quality in
one of the toughest design contests in the world," says design expert Professor
Dr. Peter Zec, the initiator of the red dot design award. Overall, designers and
companies from 57 nations took part with a total of 4,252 products in the
product design category of this year's red dot award.

The award ceremony will take place in the Essen Aalto Theater in Germany on July
5, 2010. In Essen, the European Capital of Culture in 2010, OPMI LUMERA 700 will
then be presented in a special four-week exhibition in the red dot design museum
in the Zollverein coal mine industrial complex.


Contacts:
Eva Sesselmann Patrick Kofler
Director Corporate Communications Director Investor Relations
Carl Zeiss Meditec AG Carl Zeiss Meditec AG
Göschwitzer Straße 51-52 Göschwitzer Straße 51-52
07745 Jena, Germany 07745 Jena, Germany
Phone: +49 3641 220-331 Phone: +49 3641 220-106
Fax: +49 3641 220-112 Fax: +49 3641 220-117
E-mail: press(at)meditec.zeiss.com E-mail: investors(at)meditec.zeiss.com




Brief profile
Carl Zeiss Meditec AG (ISIN: DE 0005313704), which is listed on TecDAX of the
German stock exchange, is one of the world's leading medical technology
companies.

The company supplies innovative technologies and application-oriented solutions
designed to help doctors improve the quality of life of their patients. It
provides complete packages of solutions for the diagnosis and treatment of eye
diseases - including implants and consumable materials.

The company creates innovative visualisation solutions in the field of
microsurgery. Carl Zeiss Meditec's medical technology portfolio is rounded off
by promising future technologies such as intraoperative radiation therapy.

In the financial year 2008/2009 (30 September) the 2,100 employees generated
revenue of approximately EUR 640 million. The head office of Carl Zeiss Meditec
is in Jena, Germany. The company has subsidiaries in Germany and abroad; more
than 50 percent of its employees are based in the USA, Japan, Spain and France.

35 percent of Carl Zeiss Meditec shares are in free float. The remaining 65
percent are held by Carl Zeiss AG, one of the world's leading groups engaged in
the optical and opto-electronics industry. Carl Zeiss offers innovative
solutions for the future-oriented markets of "Medical and Research Solutions",
"Industrial Solutions" and "Lifestyle Products". The head office of Carl Zeiss
AG is in Oberkochen, Germany. In financial year 2008/09 (balance sheet date 30
September) the group posted sales of around ? 2.1 billion. The Carl Zeiss Group
has approximately 13,000 employees, including more than 8,000 in Germany.

Further information: www.meditec.zeiss.com



[HUG#1411111]



--- End of Message ---

Carl Zeiss Meditec AG
Goeschwitzer Strasse 51-52 Jena Germany

WKN: 531370;ISIN: DE0005313704;Index:TecDAX,Prime All Share,TECH All Share;
Listed: Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
Freiverkehr in Börse Berlin,
Freiverkehr in Börse Düsseldorf,
Freiverkehr in Bayerische Börse München,
Freiverkehr in Niedersächsische Börse zu Hannover,
Prime Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse;






Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Net Insight appoints new Head of Corporate Communications NIB finances wind power park in northern Finland
Bereitgestellt von Benutzer: hugin
Datum: 03.05.2010 - 12:40 Uhr
Sprache: Deutsch
News-ID 20147
Anzahl Zeichen: 0

contact information:
Town:

Jena



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 269 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"OPMI LUMERA 700 from Carl Zeiss Meditec Receives Design Award"
steht unter der journalistisch-redaktionellen Verantwortung von

Carl Zeiss Meditec AG (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

ZEISS removes barriers for Minimally Invasive Spine Surgery ...

At this year?s NASS Annual Meeting in Los Angeles, USA, the ZEISS Medical Technology business segment introduces an innovative visualization system ? TIVATO? 700 from ZEISS ? to the spine community. ?When developing the ZEISS TIVATO 700 we involved e ...

Alle Meldungen von Carl Zeiss Meditec AG



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z